allegro industries

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

– Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A.

Pall Corporation (PRNewsfoto/Pall Corporation)

The new contract with Pall will establish a suspension-based manufacturing platform of up to 2000L, using a range of technologies including Allegro STR single-use bioreactors. The new installation allows for the production of a variety of viral vectors for gene therapies and viral vector-based vaccines.

Exothera recently announced a significant expansion of its manufacturing capabilities, with two new state-of-the-art Good Manufacturing Practice (GMP) facilities built at the company’s Jumet site near Brussels, Belgium . The new facilities, which are roughly 92,000 square feet and include a variety of functions from research and development to commercial production, will begin GMP production this summer.

Clive Glover , General Manager, Gene Therapy at Pall Corporation, said: “There is a strong pipeline of viral vector-based gene therapies and vaccines and the importance of rapidly realizing industrial-scale production for these vaccines and therapies has been brought into sharp focus by COVID-19. Pall has considerable process development expertise from working with many of the industry leaders to develop scalable upstream and downstream processes. We’re thrilled to bring this experience to support Exothera as they expand their manufacturing capabilities.”

The gene therapy and vaccine industries are facing complex challenges when scaling up vector-based processes. According to Vasily Medvedev , head of development at Exothera, the company selected the Pall end-to-end solution based on its flexibility and its capability to scale up processes quickly and efficiently.

“We selected Pall for their technological excellence and strong track record in the gene therapy and vaccines industries, as well as the level of support the team provides,” explained Medvedev. “They offer a robust and cost-effective single-use solution.”

Christian Borgniet, Chief Operating Officer of Exothera, added: “Compared to other suspension solutions, Pall’s STR bioreactors are well-suited and could be adapted, if needed, to the perfusion mode, allowing higher growth and density of cells. We are pleased to establish this partnership with a very supportive company that is willing to transfer its expertise.”

About Pall Corporation
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit https://www.pall.com .

Or follow us on social media:

LinkedIn   Twitter Facebook

Corporate Media Contact:  
Pall Corporation
Amanda Comeau
Director, Corporate Communications
(508) 330-0811

About Exothera SA
Exothera is a viral vector CDMO (contract manufacturing and development organization) leveraging standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

LinkedIn : https://www.linkedin.com/company/exothera / Website : www.exothera.world

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/pall-corporation-secures-multi-million-dollar-contract-with-exothera-301323764.html

SOURCE Pall Corporation

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Lithium periodic symbol and powder overlayed with world map.

Top 4 Largest Lithium Reserves by Country

Those interested in the lithium sector and investing in lithium stocks are often curious about which countries are the top producers of the battery metal, but they may not stop to consider the top lithium reserves by country.

Major lithium-producing countries are, of course, home to a large number of lithium companies. Many of the world’s top lithium producers also hold significant reserves, and their reserves can give an idea of how much room those countries have to grow. At the same time, nations with high reserves may become more significant lithium players in the future.

Looking forward, lithium demand is expected to continue increasing. That’s because, together with metals such as cobalt, lithium is a key raw material in the lithium-ion batteries used to power electric vehicles, and it is also essential for the energy storage sector.

Keep reading...Show less
Silver square with the lithium periodic symbol standing upright next to lithium metal.

Top 9 Lithium-producing Countries

Interest in lithium continues to grow due to its role in the lithium-ion batteries that power electric vehicles (EVs). As a result, more and more attention is landing on the top lithium-producing countries.

About 80 percent of the lithium produced globally goes toward battery production, but other industries also consume the metal. For example, 7 percent of lithium is used in ceramics and glass, while 4 percent goes to lubricating greases.

According to the US Geological Survey, lithium use in batteries has increased in recent years due to the use of rechargeable batteries in portable electronic devices, as well as in electric tools, EVs and grid storage applications.

Keep reading...Show less
Jindalee Lithium CEO Ian Rodger.

Jindalee Lithium Secures Funding to Advance One of the Largest Lithium Deposits in US

Jindalee Lithium (ASX:JLL,OTCQX:JNDAF) CEO Ian Rodger delves into the company’s strategy following the sale of a non-core asset and the significance of this transaction for the future development of Jindalee's flagship McDermitt lithium project in Oregon, US.

Watch the full interview with Ian Rodger, CEO of Jindalee Lithium, above.

Rapid Lithium

Investor Presentation Acquisition of the Strategic Prophet River Ge-Ga Project

Prophet River, British Columbia, Canada – Brownfields Exploration Project Strategic Metals – Germanium and Gallium

Rapid Lithium Limited (ASX:RLL) has announced Investor Presentation Acquisition of the Strategic Prophet River Ge-Ga Project.

Keep reading...Show less
Jindalee Lithium

Jindalee Realises $2.75M from Sale of Non-Core Asset

Jindalee Lithium Limited (Jindalee, the Company; ASX: JLL, OTCQX: JNDAF) advises that the Company has sold its shareholding in Dynamic Metals (ASX: DYM, Dynamic), raising $2.75M before costs.

Keep reading...Show less

Latest Press Releases

Related News

×